Do you want to read an article? Please log in or register.
β-BLOCKERS LOWER FIRST DECOMPENSATION IN PATIENTS WITH CIRRHOSIS AND ENDURING PORTAL HYPERTENSION AFTER ETIOLOGICAL TREATMENT
Hepatology
Indications
Related content
Hepatology
Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis
J Hepatol
Fortea JI, Alvarado-Tapias E, Simbrunner B, Ezcurra I, Hernández-Gea V, Aracil C, Llop E, Puente A, Roig C, Reiberger T, García-Pagan JC, Calleja JL, Ferrero-Gregori A, Mandorfer M, Villanueva C, Crespo J
doi: 10.1016/j.jhep.2024.12.017
Hepatology
Impact of first and further decompensation in patients with compensated ACLD due to MASLD
J Hepatol
Pennisi G, Di Maria G, Wai-Sun Wong V, de Ledinghen V, Sebastiani G, Viganò M, Fracanzani AL, Miele L, Bugianesi E, Ekstedt M, D'Ambrosio R, Ravaioli F, Schepis F, Marra F, Aghemo A, Svegliati-Baroni G, Persico M, Valenti L, Berzigotti A, George J, Armandi A, Nasr P, Kechagias S, Liguori A, Saltini D, Mendoza YP, Calvaruso V, Enea M, Lin H, Infantino G, Masarone M, Pugliese N, Tulone A, Di Marco V, Cammà C, Petta S
doi: 10.1016/j.jhep.2025.06.014
Hepatology
Prognostic Communication, Symptom Burden, Psychological Distress, and Quality of Life Among Patients with Decompensated Cirrhosis
Clin Gastroenterol Hepatol
Donlan J, Kaplan A, Noll A, Pintro K, Horick N, Zeng C, Edelen M, Soetan Z, Comrie C, Indriolo T, Li L, Zhu E, Armstrong ME, Thompson LL, Zhou J, Diop MS, Mason N, Engel KG, Rowland M, Kenimer S, O'Brien K, Lai JC, Jackson V, Chung RT, El-Jawahri A, Ufere NN
doi: 10.1016/j.cgh.2024.10.017
Hepatology
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study
Lancet Gastroenterol Hepatol
Patidar KR, Ma AT, Juanola A, Barone A, Incicco S, Kulkarni AV, Hernández JLP, Wentworth B, Asrani SK, Alessandria C, Abdelkader NA, Wong YJ, Xie Q, Pyrsopoulos NT, Kim SE, Fouad Y, Torre A, Cerda E, Ferrer JD, Maiwall R, Simonetto DA, Papp M, Orman ES, Perricone G, Solé C, Lange CM, Farias AQ, Pereira G, Gadano A, Caraceni P, Thevenot T, Verma N, Kim JH, Vorobioff JD, Cordova-Gallardo J, Ivashkin V, Roblero JP, Maan R, Toledo C, Gioia S, Fassio E, Marino M, Nabilou P, Vargas V, Merli M, Goncalves LL, Rabinowich L, Krag A, Balcar L, Montes P, Mattos AZ, Bruns T, Mohammed A, Laleman W, Carrera E, Cabrera MC, Girala M, Samant H, Raevens S, Madaleno J, Kim RW, Arab JP, Presa J, Ferreira CN, Galante A, Allegretti AS, Takkenberg B, Marciano S, Sarin SK, Durand F, Ginès P, Angeli P, Solà E, Piano S, International Club of Ascites GLOBAL AKI team
doi: 10.1016/S2468-1253(25)00006-8
Hepatology
Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis
Gut
Trebicka J, Aguilar F, Queiroz Farias A, Lozano JJ, Sánchez-Garrido C, Usón-Raposo E, de la Peña-Ramirez C, Sidorova J, Curto-Vilalta A, Sierra-Casas P, Momoyo Zitelli P, Papp M, Pereira G, Caraceni P, Goncalves LL, Alessandria C, Torre A, Laleman W, Gadano A, Piano S, Mattos AZ, Gu W, Brol MJ, Schierwagen R, Uschner FE, Fischer J, Mendes LSC, Vargas V, Alvares-da-Silva MR, Mookerjee R, Bittencourt PL, Benitez C, Albillos A, Couto C, Mendizabal M, Bañares R, Toledo CL, Mazo DF, Janicko M, Castillo-Barradas M, Padilla Machaca PM, Gatti P, Miranda AZ, Malé-Velázquez R, Zipprich A, Castro-Lyra A, Gustot T, Bernal W, Gerbes AL, Jalan R, Fernández J, Angeli P, Carrilho FJ, Claria J, Moreau R, Arroyo V, PREDICT study and ACLARA study
doi: 10.1136/gutjnl-2024-333876
Inflammatory Bowel Disease
Clinical outcomes after first-line anti-TNF treatment of patients with inflammatory bowel disease - a prospective multicenter cohort study
J Crohns Colitis
Zhao M, Larsen L, Dige A, Poulsen A, Lo B, Attauabi M, Dige Ovesen P, Wewer MD, Christiansen D, Hvas CL, Petersen AM, Bendtsen F, Seidelin J, Burisch J
doi: 10.1093/ecco-jcc/jjae192
Hepatology
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study
Lancet Gastroenterol Hepatol
Jachs M, Odriozola A, Turon F, Moga L, Téllez L, Fischer P, Saltini D, Kwanten WJ, Grasso M, Llop E, Mendoza YP, Armandi A, Thalhammer J, Pardo C, Colecchia A, Ravaioli F, Maasoumy B, Laleman W, Presa J, Schattenberg JM, Berzigotti A, Calleja JL, Calvaruso V, Francque S, Schepis F, Procopet B, Albillos A, Rautou PE, García-Pagán JC, Puente Á, Fortea JI, Reiberger T, Mandorfer M, SSM-100Hz/ACLD Study Group, Baveno Cooperation
doi: 10.1016/S2468-1253(24)00234-6
Gastrointestinal Cancer
Reliable Performance of mALBI Grade-Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First-Line Treatment: Comparative Analysis of 13 Risk Models
J Gastroenterol Hepatol
Hatanaka T, Kakizaki S, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Toyoda H, Ogawa C, Nishikawa H, Nishimura T, Kawata K, Kosaka H, Naganuma A, Yata Y, Ohama H, Kuroda H, Matono T, Tanaka K, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Kumada T, Real‐life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
doi: 10.1111/jgh.16871
Inflammatory Bowel Disease
Treatment sequences, outcomes, healthcare utilization, and costs in patients with inflammatory bowel diseases requiring advanced treatment-real world comparative effectiveness from German claims data
BMC Gastroenterol
Dignass A, Teich N, Kaiser S, Sünwoldt J, Dünweber C, Weinhold I, Borchert J, Kudernatsch R
doi: 10.1186/s12876-025-04022-7